Magnetic Resonance in Medicine · 2012 · 59 citations · 19 references
MedicineOncologyRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyMagnetic Resonance ImagingMagnetic Resonance Imaging PhysicsMedical ImagingProstate CancerProstate Cancer ImagingTumor ImagingImage Contrast EvaluationImage Contrast MechanismsProstate Cancer DiagnosisProstate Disease ImagingQuantitative Relaxation MappingQuantum InterferenceSuperconducting Quantum Interference Device MagnetometryT1 Contrast
The proton T(1) was measured at 132 μT in ex vivo prostate tissue specimens from radical prostatectomies of 35 patients with prostate cancer. Each patient provided two specimens. The NMR and MRI measurements involved proton repolarization, a field of typically 150 mT and detection of the 5.6-kHz signal with a superconducting quantum interference device. Values of T(1) varied from 41 to 86 ms. Subsequently, the percentages of tissue types were determined histologically. The theoretical image contrast is quantified for each case by δ = [1 - T(1) (more cancer)/T(1) (less cancer)]. A linear fit of δ versus difference in percentage cancer yields T(1) (100% cancer)/T(1) (0% cancer) = 0.70 ± 0.05 with correlation coefficient R(2) = 0.30. Two-dimensional T(1) maps for four specimens demonstrate variation within a single specimen. These results suggest that MR images with T(1) contrast established at ultra-low fields may discriminate prostate cancer from normal prostate tissue in vivo without a contrast agent.
19
Arnauld Villers, Philippe Puech, Damien Mouton et al. · The Journal of Urology · 2006 · 371 citations